Drug recall
Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC…
FDA recall event 85724 · Class II · PD-Rx Pharmaceuticals, Inc.
Key facts
| Event ID | 85724 |
|---|---|
| Recall numbers | D-1276-2020 |
| Recalling firm | PD-Rx Pharmaceuticals, Inc. |
| Product type | Drugs |
| Products | Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC 55289-866-10), c) 14-count (NDC 55289-866-14), d) 20-count (NDC 55289-866-20), e) 28-count… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed dissolution specifications |
| Initiation date | May 15, 2020 |
| Report date | Jun 3, 2020 |
| Termination date | Nov 8, 2021 |
| City | Oklahoma City |
| State | OK |
| Country | United States |
| FEI number | 1641825 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: